[1]
S. De Leo, “Effectiveness of the mRNA BNT162b2 vaccine against SARS-CoV-2 severe infections in the Israeli over 60 population: a temporal analysis done by using the national surveillance data: Effectiveness of the mRNA BNT162b2 vaccine”, jmrhs, vol. 4, no. 10, pp. 1511–1517, Oct. 2021.